Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

28.62
-0.2550-0.88%
Post-market: 28.740.1250+0.44%19:55 EDT
Volume:3.47M
Turnover:98.73M
Market Cap:3.21B
PE:-24.81
High:29.01
Open:28.91
Low:27.69
Close:28.87
Loading ...
Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 02, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 26, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 25, 2023

Major Issues Report

Form 8-K - Current report
Jul 27, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 26, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
May 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 11, 2023

Major Issues Report

8-K - Current report
May 01, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 26, 2023

Major Issues Report

8-K - Current report
Apr 26, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 24, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 19, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities